Related Experiment Video

Updated: May 11, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Landmark lipid-lowering trials in the primary prevention of cardiovascular disease

Jonathan Chrispin1, Seth S Martin, Rani K Hasan

  • 1The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins School of Medicine, Baltimore, Maryland.

Clinical Cardiology
|June 1, 2013
PubMed

Insights

Lipid-lowering therapies effectively reduce cardiovascular disease (CVD) risk and mortality by targeting atherogenic lipoproteins. This review examines clinical trials of these medications, offering a framework for managing patient cardiovascular risk.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Atherosclerotic cardiovascular disease (CVD) is a leading global cause of death.
  • Lifelong exposure to atherogenic lipoproteins significantly elevates CVD event risk.
  • Lipid-lowering therapies have advanced over 25 years, demonstrating efficacy in reducing cholesterol and adverse cardiovascular outcomes.

Purpose of the Study:

  • To review key clinical trials of lipid-lowering medications.
  • To provide an evidence-based framework for managing cardiovascular risk.
  • To highlight the role of lipid management in preventing CVD events and mortality.

Main Methods:

  • Review of pivotal clinical trials across various lipid-lowering drug classes.
  • Analysis of data demonstrating the impact of these therapies on lipid levels and CVD events.
  • Synthesis of evidence supporting the use of lipid-lowering medications in clinical practice.

Main Results:

  • Lipid-lowering therapies demonstrably reduce cholesterol levels.
  • These medications have been proven to decrease the incidence of major adverse cardiovascular events.
  • Evidence supports a reduction in cardiovascular disease mortality with effective lipid management.

Conclusions:

  • Lipid-lowering therapies are crucial for managing atherosclerotic cardiovascular disease risk.
  • An evidence-based approach using these medications is essential for preventing CVD events and mortality.
  • Clinicians can utilize trial data to guide therapeutic decisions for cardiovascular risk reduction.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...